Paper36453048
The estimated lifetime risk of revision after primary knee arthroplasty is influenced by age, sex, and indication.
Yapp LZ and 5 others. Bone Joint J, 2022. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. The estimated lifetime risk of revision after primary knee arthroplasty is influenced by age, sex, and indication. Papers, record 36453048. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36453048
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The estimated lifetime risk of revision after primary knee arthroplasty is influenced by age, sex, and indication.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Arthroplasty, Replacement, Knee | Major topic |
| Osteoarthritis | Major topic |
| Humans | |
| Male | |
| Aged, 80 and over | |
| Middle Aged | |
| Aged | |
| Reoperation | |
| Life Tables |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42626536 | Bilateral Revision for Periprosthetic Osteolysis Around Primary Total Knee Prostheses: A Case Report. | Cureus | 2026 | https://conductscience.org/library/papers/42626536 | PubMed |
| 41774216 | Ten-year functional outcomes and up to 18-year survivorship of computer-navigated total knee arthroplasty: analysis of 1677 cases from a high-volume centre. | Eur J Orthop Surg Traumatol | 2026 | https://conductscience.org/library/papers/41774216 | PubMed |
| 41718643 | Similar incidence and implant survival of multiply revised knee arthroplasties in Norway and Denmark: a register study of the Danish and Norwegian Knee Arthroplasty registries from 1998-2021. | Acta Orthop | 2026 | https://conductscience.org/library/papers/41718643 | PubMed |
| 40763924 | Knee arthroplasty compared with joint distraction for osteoarthritis: a phase III randomized controlled trial. | Bone Jt Open | 2025 | https://conductscience.org/library/papers/40763924 | PubMed |
| 39797286 | Are Current Patient-Reported Outcome Measures Fit for Purpose to Evaluate Unicompartmental Knee Arthroplasty? | J Clin Med | 2025 | https://conductscience.org/library/papers/39797286 | PubMed |
| 39717839 | Double-Butter: A Cementation Technique That Significantly Reduces Lipid Contamination of the Tibial Baseplate in Total Knee Arthroplasty. | Arthroplast Today | 2024 | https://conductscience.org/library/papers/39717839 | PubMed |
| 37843609 | Development of application and surgical technique of total knee arthroplasties: a systematic comparative analysis using worldwide registers. | Arch Orthop Trauma Surg | 2024 | https://conductscience.org/library/papers/37843609 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36453048
GET https://conductscience.org/api/papers/v1/36453048/authors